Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303

Galsky, Matthew D.; Hoimes, Christopher J.; Necchi, Andrea; Shore, Neal; Witjes, J. Alfred; Steinberg, Gary; Bedke, Jens; Nishiyama, Hiroyuki; Fang, Xiao; Kataria, Ritesh; Sbar, Eric; Jia, Xieyang; Siefker-Radtke, Arlene

dc.contributor.author	Bedke, Jens
dc.date.accessioned	2021-12-06T08:17:04Z
dc.date.available	2021-12-06T08:17:04Z
dc.date.issued	2021
dc.identifier.issn	1744-8301
dc.identifier.uri	http://hdl.handle.net/10900/121404
dc.language.iso	en	de_DE
dc.publisher	Future Medicine Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2217/fon-2021-0273	de_DE
dc.subject.ddc	610	de_DE
dc.title	Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_01155
utue.publikation.seiten	3137-3150	de_DE
utue.personen.roh	Galsky, Matthew D.
utue.personen.roh	Hoimes, Christopher J.
utue.personen.roh	Necchi, Andrea
utue.personen.roh	Shore, Neal
utue.personen.roh	Witjes, J. Alfred
utue.personen.roh	Steinberg, Gary
utue.personen.roh	Bedke, Jens
utue.personen.roh	Nishiyama, Hiroyuki
utue.personen.roh	Fang, Xiao
utue.personen.roh	Kataria, Ritesh
utue.personen.roh	Sbar, Eric
utue.personen.roh	Jia, Xieyang
utue.personen.roh	Siefker-Radtke, Arlene
dcterms.isPartOf.ZSTitelID	Future Oncology	de_DE
dcterms.isPartOf.ZS-Issue	24	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE